Researchers find hope in diabetes battle

Sep 16, 2006

Canadian researchers have found what they hope is a magic bullet in combating diabetes.

McMasters University scientists are crediting extra use by the commonly prescribed Rosiglitazone for the hope of cutting the diabetes epidemic in half, the Hamilton Spectator said.

Widely used to treat type 2 diabetes, Rosiglitazone has been found effective for those at highest risk because of genetics, age or obesity, making it what researchers call the first line of defense for diabetes.

The results of the $25 million study were presented Friday at the annual meeting of the European Association for the Study of Diabetes in Copenhagen.

Copyright 2006 by United Press International

Explore further: Eight signs of back to school anxiety in children

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Study highlights concern for homeless seniors

29 minutes ago

A new study for the Greater Victoria Coalition to End Homelessness, co-authored by researchers at the University of Victoria and Simon Fraser University, has found that a disproportionate number of people chronically staying ...

Survey finds benefits, risks of yoga for bipolar disorder

58 minutes ago

Right now no one can say whether yoga provides clinical benefits to people with bipolar disorder, but in a new article in the Journal of Psychiatric Practice, researchers report survey responses they gather ...

User comments : 0